Abbott Kicks Off Diabetes Control For Life Program In China
This article was originally published in PharmAsia News
Executive SummaryTo tap the growing diabetes market in China, multinational pharmaceutical companies are competing to find new ways to educate consumers and advertise their products. At a recent seminar on the progress of international diabetes nutrition therapy, Abbott introduced its new diabetes management plan - Diabetes Control for Life. The free 24-week diabetes management program allows diabetics to better control their blood glucose and helps them fight the disease through a healthy lifestyle. The DCFL plan has been launched in the U.S. and China experts are conducting a comparative study. (Click here for more - Chinese Language)
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.